This inventor holds 1 USPTO granted patent. Top assignee: Melio Healthcare Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jeremy Mason and Immune System Phenotyping Innovation.
Introduction
Jeremy Mason is an inventor based in Cambridge, Great Britain. His patent work concerns standardized immune system phenotyping and automated classification of immune cells, combining laboratory analysis with machine learning.
Latest Patents
Mason is associated with 1 patent, titled “Systems and Methods for Comprehensive and Standardized Immune System Phenotyping and Automated Cell Classification.” The invention describes methods for generating an immune profile from a subject’s sample. Cells are fluorescently labeled using an immunophenotyping panel and analyzed with a full-spectrum flow cytometer. An ensemble machine-learning model then classifies individual cells into distinct immune cell subpopulations, and the system reports a total cell count or frequency for each population.
Career Highlights
Mason is associated with Melio Healthcare Limited. His patent reflects an approach to making immune-cell analysis more comprehensive and standardized by integrating flow-cytometry data with automated classification.
Collaborations
The provided information identifies Eduardo Alves and Jennie Yang as Mason’s coworkers. Their specific roles in the patent or related work are not stated.
Conclusion
Jeremy Mason’s patent brings together immunophenotyping, full-spectrum flow cytometry, and machine learning to support the generation of detailed immune profiles.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile